Junior investigators successfully compete for extra NIH grants

September 13, 2018

More than half of early-career scientists who received their first research project (R01) grants from the National Institute of Allergy and Infectious Diseases (NIAID) are successful in obtaining subsequent funding from the National Institutes of Health (NIH), according to a study published September 12 in the open-access journal PLOS ONE by Patricia Haggerty and Matthew Fenton of NIAID, an NIH institute.

The survival of junior scientists in academic biomedical research is difficult in today's highly competitive funding climate. NIH data on first-time R01 grantees indicate the rate at which early investigators drop out from an NIH-supported research career is most rapid four to five years from the first R01 award. The factors associated with a high risk of dropping out, and whether these factors impact all junior investigators equally, are unclear. In the new study, Haggerty and Fenton set out to better understand how first-time NIAID awardees compete for subsequent R01 awards and what their funding outcomes were.

The researchers identified a cohort of 1,496 investigators who received their first R01-equivalent (R01-e) awards from NIAID between 2003 and 2010, and studied all their subsequent NIH grant applications through 2016. Ultimately, 57% of the cohort were successful in obtaining new R01-e funding, despite highly competitive conditions that favored more senior investigators. The early-career scientists who successfully obtained new grants consistently submitted more applications per year, more renewal applications, and more applications to multiple NIH Institutes. Funded investigators had better scores on their first R01-e grants and demonstrated an early ability to write better applications that would be scored instead of triaged.

Haggerty notes: "When we compared grant submission behaviors and grant quality indices, what emerged was the profile of the tenacious, successful early NIH-funded investigators, who developed superior grant writing skills, superior grant submission strategies, and projects with broad relevance and scope. These are skills that can be modeled and taught."
-end-
In your coverage please use this URL to provide access to the freely available article in PLOS ONE: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0199648

Citation: Haggerty PA, Fenton MJ (2018) Outcomes of early NIH-funded investigators: Experience of the National Institute of Allergy and Infectious Diseases. PLoS ONE 13(9): e0199648. https://doi.org/10.1371/journal.pone.0199648

Funding: The authors received no specific funding for this work.

Competing Interests: The authors have declared that no competing interests exist.

PLOS

Related Infectious Diseases Articles from Brightsurf:

Understanding the spread of infectious diseases
Physicists at M√ľnster University (Germany) have shown in model simulations that the COVID-19 infection rates decrease significantly through social distancing.

Forecasting elections with a model of infectious diseases
Election forecasting is an innately challenging endeavor, with results that can be difficult to interpret and may leave many questions unanswered after close races unfold.

COVID-19 a reminder of the challenge of emerging infectious diseases
The emergence and rapid increase in cases of coronavirus disease 2019 (COVID-19), a respiratory illness caused by a novel coronavirus, pose complex challenges to the global public health, research and medical communities, write federal scientists from NIH's National Institute of Allergy and Infectious Diseases (NIAID) and from the Centers for Disease Control and Prevention (CDC).

Certain antidepressants could provide treatment for multiple infectious diseases
Some antidepressants could potentially be used to treat a wide range of diseases caused by bacteria living within cells, according to work by researchers in the Virginia Commonwealth University School of Medicine and collaborators at other institutions.

Opioid epidemic is increasing rates of some infectious diseases
The US faces a public health crisis as the opioid epidemic fuels growing rates of certain infectious diseases, including HIV/AIDS, hepatitis, heart infections, and skin and soft tissue infections.

Infectious diseases could be diagnosed with smartphones in sub-Saharan Africa
A new Imperial-led review has outlined how health workers could use existing phones to predict and curb the spread of infectious diseases.

The Lancet Infectious Diseases: Experts warn of a surge in vector-borne diseases as humanitarian crisis in Venezuela worsens
The ongoing humanitarian crisis in Venezuela is accelerating the re-emergence of vector-borne diseases such as malaria, Chagas disease, dengue, and Zika virus, and threatens to jeopardize public health gains in the country over the past two decades, warn leading public health experts.

Glow-in-the-dark paper as a rapid test for infectious diseases
Researchers from Eindhoven University of Technology (The Netherlands) and Keio University (Japan) present a practicable and reliable way to test for infectious diseases.

Math shows how human behavior spreads infectious diseases
Mathematics can help public health workers better understand and influence human behaviors that lead to the spread of infectious disease, according to a study from the University of Waterloo.

Many Americans say infectious and emerging diseases in other countries will threaten the US
An overwhelming majority of Americans (95%) think infectious and emerging diseases facing other countries will pose a 'major' or 'minor' threat to the U.S. in the next few years, but more than half (61%) say they are confident the federal government can prevent a major infectious disease outbreak in the US, according to a new national public opinion survey commissioned by Research!America and the American Society for Microbiology.

Read More: Infectious Diseases News and Infectious Diseases Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.